Status:
COMPLETED
Incidence and Outcomes Associated With the Management of Adenovirus Infections in Allogenic Hematopoietic Cell Transplant Recipients
Lead Sponsor:
Jazz Pharmaceuticals
Conditions:
Adenovirus Infections, Human
Eligibility:
All Genders
Up to 90 years
Brief Summary
To depict the incidence, outcomes and standards of care (SoC) of adenovirus (AdV) infections and associated practice patterns in allogeneic hematopoietic cell transplant recipients. It is expected tha...
Eligibility Criteria
Inclusion
- At least one AdV positive test, regardless of specimen within 6 months following the first allo-HCT
- Subjects first allo-HCT must have been performed between 1 January 2013 and 30 September 2015
Exclusion
- AdV negative
Key Trial Info
Start Date :
January 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2017
Estimated Enrollment :
216 Patients enrolled
Trial Details
Trial ID
NCT04285788
Start Date
January 1 2013
End Date
January 1 2017
Last Update
March 25 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.